Medications for opioid use disorder

Results 241 to 250 of about 35,674 (297)

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley +1 more source

Telemedicine to improve access to medications for opioid use disorder in Illinois, 2022-2024. [PDF]

Int J Drug Policy
Gressick K +7 more
europepmc +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source

Situational confidence and recovery capital among justice-involved adults receiving medications for opioid use disorder in a jail-based setting. [PDF]

Health Justice
Obekpa EO +6 more
europepmc +1 more source

Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience

Addiction, EarlyView.
Julien Cabé, Georges Brousse
wiley +1 more source

Critical care delirium: prevention, identification and management: a narrative review

Anaesthesia, EarlyView.
Summary Introduction Delirium is a frequent complication of critical illness and remains an important cause of short‐ and long‐term morbidity for patients admitted to ICUs. Delirium is associated with prolonged mechanical ventilation; extended ICU and hospital stay; and longer‐term health issues. Development is associated with patient (e.g.
Stephanie Kieswick, Ben Gibbison
wiley +1 more source

Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery (POPPY): short‐term peri‐operative analgesic use

Anaesthesia, EarlyView.
Summary Introduction An increasing proportion of complex surgical procedures are being performed in the UK as day‐cases, with variable and limited follow up. Discharge prescriptions must provide adequate analgesia, while considering the safety of the patient and public, following best practice guidance and good opioid stewardship.
Anna Ratcliffe +2083 more
wiley +1 more source

Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. [PDF]

Health Aff Sch
Ganz DA +6 more
europepmc +1 more source

Testosterone Versus Clomiphene Treatment of Hypogonadism: A Retrospective Analysis in US Veterans

Andrology, EarlyView.
ABSTRACT Background Male hypogonadotropic hypogonadism is a complex condition with a multifactorial etiology. Although testosterone replacement therapy (TRT) is the only approved treatment for male hypogonadism, clomiphene citrate (CC) is often used as an off‐label treatment.
Shourya Tadisina +6 more
wiley +1 more source

Clinician Perspectives on Barriers and Facilitators to Providing Medications for Opioid Use Disorder for Adolescents. [PDF]

J Addict Med
Ruth J +4 more
europepmc +1 more source

buprenorphine
analgesics, opioid
opiate substitution treatment

methadone
3. good health
naltrexone